Cite

HARVARD Citation

    Nitta, R. et al. (n.d.). CSIG-44. TREATMENT WITH THE CASEIN KINASE 2 INHIBITOR, CX-4945, SENSITIZES MEDULLOBLASTOMA TO TEMOZOLOMIDE. Neuro-oncology. pp. vi52-vi53. [Online]. 
  
Back to record